Litcius/Paper detail

Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

Ivan T. Lee, Catherine A. Cosgrove, Patrick Moore, Claire Bethune, Rhiannon Nally, Marcin Bula, Philip A. Kalra, Rebecca A. Clark, Paul I. Dargan, Marta Boffito, Ray Sheridan, Ed Moran, Thomas C. Darton, Fiona Burns, Dinesh Saralaya, C.J. Duncan, Patrick Lillie, Alberto San Francisco Ramos, Eva Galiza, Paul T. Heath, Bethany Girard, Christy Parker, Dondi Rust, Shraddha Mehta, Elizabeth de Windt, Andrea Sutherland, Joanne E. Tomassini, Frank J. Dutko, Spyros Chalkias, Weiping Deng, Xing Chen, Jing Feng, LaRee Tracy, Honghong Zhou, Jacqueline M. Miller, Rituparna Das, Claire Bethune, Marta Boffito, Duncan L. Browne, Marcin Bula, Fiona Burns, David Chadwick, Rebecca A. Clark, Catherine A. Cosgrove, Paul I. Dargan, Thomas C. Darton, C.J. Duncan, Stevan R. Emmett, Eva Galiza, James Galloway, Paul T. Heath, Lucy Jones, Philip A. Kalra, R.M. Kaminski, Rajeka Lazarus, Patrick Lillie, Patrick Moore, Ed Moran, Rhiannon Nally, Adrian Palfreeman, Alberto San Francisco Ramos, Tommy Rampling, Anju Sahdev, Dinesh Saralaya, Ray Sheridan, Roy L. Soiza

2023The Lancet Infectious Diseases53 citationsDOIOpen Access PDF

Topics & Concepts

ImmunogenicityBooster (rocketry)MedicineBivalent (engine)Booster doseVaccinationClinical trialRandomized controlled trialAntibody responseCoronavirus disease 2019 (COVID-19)Internal medicineAntibodyImmunologyTiterDiseaseChemistryPhysicsOrganic chemistryInfectious disease (medical specialty)MetalAstronomySARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesIntramuscular injections and effects
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial | Litcius